Abstract
Aims
Atrial fibrillation (AF) occurs commonly in patients with acute myocardial infarction (AMI) and has been established as a marker of adverse prognosis. There are only few clinical trials that investigate differences between new-onset and chronic AF in AMI. We hypothesize that chronic AF is associated with an increased rate of adverse short- and long-term outcomes.
Methods and results
In a single center study, over a period of 28 months, 375 consecutive patients with AMI were included [337 patients without AF (89.9%) and 38 with AF (10.1%)]. As much as 16 patients had new-onset AF (42.1%) and 22 had chronic AF (57.9%). Patients with severe coronary artery disease develop AF more often in AMI, and the existence of AF was associated with a poor prognosis. Compared to patients with new-onset AF, chronic AF was more frequently associated with advanced age (75 vs. 70 years, p not significant), reduced left ventricular ejection fraction (44.8 vs. 54.0%, p < 0.05) and NSTEMI (63.6 vs. 36.4%, p < 0.05). Only chronic AF resulted in increased in-hospital death (18.2 vs. 0.0%; p < 0.005) at the 2-year follow-up, 14 patients with AF died (63.6%), predominantly due to cardiovascular reasons.
Conclusion
Our results indicate that patients with chronic AF had a higher incidence of in-hospital death than those with new-onset AF or without. Chronic AF includes a group of older and sicker patients than their counterparts with new-onset AF. Understanding these findings may ultimately lead to better care of patients with this arrhythmia to prevent the development of the underlying atrial substrate in chronic AF patients and to improve their otherwise worse prognosis.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- AMI:
-
Acute myocardial infarction
- CAD:
-
Coronary artery disease
- LAD:
-
Left anterior descending coronary artery
- LCx:
-
Left circumflex coronary artery
- LVEF:
-
Left ventricular ejection fraction
- NSTEMI:
-
Non-ST elevation myocardial infarction
- OAC(s):
-
Oral anticoagulant(s)
- PCI:
-
Primary coronary intervention
- RCA:
-
Right coronary artery
- STEMI:
-
ST-elevation myocardial infarction
References
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952
Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB (2007) Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol 49:986–992
Lopes RD, Pieper KS, Horton JR et al (2008) Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 94:867–873
Pizzetti F, Turazza FM, Franzosi MG et al (2001) Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 86:527–532
Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H (1992) Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J 13:45–50
Pedersen OD, Bagger H, Kober L, Torp-Pedersen C (1999) The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction TRACE Study group TRAndolapril Cardiac Evalution. Eur Heart J 20:748–754
Rathore SS, Berger AK, Weinfurt KP et al (2000) Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 101:969–974
Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohmann EM (2002) GUSTO-III Investigators Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. Heart 88:357–362
Pritchett ELC (1992) Management of atrial fibrillation. N Engl J Med 326:1264–1271
Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, Gore JM, Alpert JS, Dalen JE (1990) Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction A community-wide perspective. Am Heart J 119:996–1001
Sakata K, Kurihara H, Iwamori K et al (1997) Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol 80:1522–1527
Schmitt J, Duray G, Gersh BJ, Hohnloser SH (2009) Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 30:1038–1045
Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D (2003) Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 92:1150–1154
Mehta RH, Dabbous OH, Granger CB et al (2003) Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 92:1031–1036
Al-Khatib SM, Pieper KS, Lee KL et al (2001) Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol 88(A7):76–79
Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P (2009) Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up. Int J Clin Pract 63:712–721
Campbell CL, Steinhubl SR (2008) Atrial fibrillation in the setting of acute myocardial infarction–irregulary irregular treatment. A Heart J 155(2):197–199
Cappato R (2009) Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented. Eur Heart J 30:1035–1037
Killip T III, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20(4):457–464
Gage BF, Watermann AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870
Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Task force for percutaneous coronary interventions of the European Society of Cardiology Guidelines for Percutaneous Coronary Interventions. Eur Heart J 26:804–847
Lehto M, Snapinn S, Dickstein K, Swedberg K, Niemienen MS (2005) OPTIMAAL Investigators Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 26:350–356
Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM (1997) Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 30:406–413
Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E (1998) Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era SPRINT and Thrombolytic Survey Groups. Circulation 97:965–970
Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P (2009) Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 104(10):1317–1323
Stenestrand U, Lindback J, Wallentin L (2005) Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation 112:3225–3231
Meissner A, Plehn G et al. (2009) First experiences for pulmonary vein isolation with the high-density mesh ablator (HDMA): a novel mesh electrode catheter for both mapping and radiofrequency delivery in a single unit. J Cardiovasc Electrophysiol. 20(4):359–366
Pappone C, Rosanio S, Augello G et al (2003) Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42:185–197
Sanders P, Jaïs P, Hocini M et al (2004) Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm 1:176–184
Wazni OM, Marrouche NF, Martin DO et al (2005) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293:2634–2640
Khan MN, Jaïs P, Cummings J et al (2008) Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 359:1778–1785
Meissner A, Plehn G et al. (2009) Segmental pulmonary vein isolation in atrial fibrillation: new insights from the high density mesh mapper technique in an electrophysiologically guided approach. J Interv Card Electrophysiol 25(3):183–192
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maagh, P., Butz, T., Wickenbrock, I. et al. New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin Res Cardiol 100, 167–175 (2011). https://doi.org/10.1007/s00392-010-0227-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-010-0227-6